Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 5 47-5, 2000, Pages

  Kauser, Katalin ^a   Da Cunha, Valdeci ^a   Fitch, Richard ^a   Mallari, Cornell ^a   Rubanyi, Gabor M ^a  

^a BAYER AG   (Germany)

Author keywords

Endothelium; L arginine; N nitro L arginine methyl ester; Plaque development and progression

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN E; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM; LIPID BLOOD LEVEL; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034129619     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.5.h1679     Document Type: Article

References (33)

1. Aji W, Ravalli S, Szabolcs M, Jiang XC, Sciacca RR, Michler RE, and Cannon PJ. L-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 95: 430-437, 1997.
2. Bonthu S, Heistad DD, Chappell DA, Lamping KG, and Faraci FM. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol 17: 2333-2340, 1997.
3. Bult H. Nitric oxide and atherosclerosis: possible implications for therapy. Mol Med Today 2: 510-518, 1996.
4. Cayatte AJ, Palacino JJ, Horten K, and Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14: 753-759, 1994.
5. Cooke JPA, Singer H, Tsao P, Zera P, Rowan RA, and Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90: 1168-1172, 1992.
6. Creager MA, Gallagher SJ, Girerd XJ, Colman SM, Dzau VJ, and Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90: 1248-1253, 1992.
7. Elhage R, Bayard F, Richard V, Holvoet P, Duverger N, Fiévet C, and Arnal J-F. Prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 96: 3048-3052, 1997.
8. Feron O, Dessy C, Moniotte S, Desager JP, and Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103: 897-905, 1999.
9. Feron O, Michel JB, Sase K, and Michel T. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry 37: 193-200, 1998.
10. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase akt. Nature 399: 597-601, 1999.
11. Garcia-Cardeña G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, and Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 272: 25437-25440, 1997.
12. Harri son DG. Endothelial dysfunction in atherosclerosis. Basic Res Cardiol 89: 87-102, 1994.
13. Harri son DG. Perspective series: nitric oxide and nitric oxide synthases. J Clin Invest 100: 2153-2157, 1997.
14. Hayashi T, Fujuto JM, Ignarro LJ, and Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 89: 11259-11263, 1992.
15. Lamping KG, Nuno DW, Chappell DA, and Faraci FM. Agonist-specific impairment of coronary vascular function in genetically altered hyperlipidemic mice. Am J Physiol Regulatory Integrative Comp Physiol 276: R1023-R1029, 1999.
16. Liu J, Garcia-Cardeña G, and Sessa WC. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35: 13277-13281, 1996.
17. Lüscher TF and Noll G. Endothelial function as an end-point in interventional trials: concepts, methods and current data. J Hypertens 14: S111-S121, 1996.
18. MacAllister RJ, Fickling SA, St G. Whitley J, and Vallance P. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 112: 43-48, 1994.
19. Mian BK and Martin W. Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta. Br J Pharmacol 115: 993-1000, 1995.
20. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, and Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99: 1141-1146, 1999.
21. Nakashima Y, Plump AS, Raines EW, Breslow JL, and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140, 1994.
22. Naruse KM, Shimizu M, Muramatsu M, Toki Y, Miyazaki Y, Okurama K, Hashimoto H, and Ito T. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. Arterioscler Thromb 14: 746-756, 1994.
23. Nascimento CAD, Kauser K, and Rubanyi GM. Effect of 17β-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. Am J Physiol Heart Circ Physiol 276: H1788-H1794, 1999.
24. Pritchard, KAJr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, and Stemerman MB. Native low density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 77: 510-518, 1995.
25. Romics L, Hesz A, Csuka I, Antoni F, and Karadi I. The effect of low-density lipoprotein (LDL) on NO formation and on arginase activity in mouse peritoneal macrophages. Orv Hetil 133: 1359-1362, 1992.
26. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, and Korach KS. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99: 2429-2437, 1997.
27. Rubanyi GM and Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H822-H827, 1986.
28. Sukovich DA, Kauser K, Shirley FD, DelVecchio V, Halks-Miller M, and Rubanyi GM. Expression of interleukin-6 in atherosclerotic lesions of male apoE-knockout mice inhibition by 17β-estradiol. Arterioscler Thromb Vasc Biol 18: 1498-1505, 1998.
29. Tse J, Martin-McNaulty B, Halks-Miller M, Kauser K, DelVecchio V, Vergona R, Sullivan ME, and Rubanyi GM. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male apo-e knockout mice can be prevented by chronic treatment with 17β-estradiol. Atherosclerosis 144: 303-313, 1999.
30. Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J 18: E19-E29, 1997.
31. Weiss D and Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-knockout mice (Abstract). FASEB J 13: A692, 1999.
32. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, and Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17: 2479-2488, 1997.
33. Zeiher AM, Drexler H, Wollschläger H, and Just H. Endothelial dysfunction of coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 84: 1984-1992, 1991.